Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Itacitinib (INCB039110) is an orally bioavailable inhibitor of Janus-associated kinase 1 (JAK1) with potential antineoplastic activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 45.00 | |
2 mg | In stock | $ 65.00 | |
5 mg | In stock | $ 113.00 | |
10 mg | In stock | $ 189.00 | |
25 mg | In stock | $ 343.00 | |
50 mg | In stock | $ 572.00 | |
100 mg | In stock | $ 822.00 | |
500 mg | In stock | $ 1,630.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 139.00 |
Description | Itacitinib (INCB039110) is an orally bioavailable inhibitor of Janus-associated kinase 1 (JAK1) with potential antineoplastic activity. |
In vitro | Itacitinib is an inhibitor of the Janus kinases (JAKs) with selectivity for JAK1. |
In vivo | Itacitinib (INCB039110) produced significant improvements in sPGA, demonstrating proof of concept in chronic plaque psoriasis. |
Synonyms | INCB39110, INCB039110 |
Molecular Weight | 553.51 |
Formula | C26H23F4N9O |
CAS No. | 1334298-90-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (108.4 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Itacitinib 1334298-90-6 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells JAK inhibit Janus kinase INCB 039110 INCB39110 INCB 39110 INCB039110 INCB-039110 INCB-39110 Inhibitor inhibitor